Cargando…
A synthetic lethal screen for Snail-induced enzalutamide resistance identifies JAK/STAT signaling as a therapeutic vulnerability in prostate cancer
Despite substantial improvements in the treatment landscape of prostate cancer, the evolution of hormone therapy-resistant and metastatic prostate cancer remains a major cause of cancer-related death globally. The mainstay of treatment for advanced prostate cancer is targeting of androgen receptor s...
Autores principales: | Ware, Kathryn E., Thomas, Beatrice C., Olawuni, Pelumi D., Sheth, Maya U., Hawkey, Nathan, Yeshwanth, M., Miller, Brian C., Vietor, Katherine J., Jolly, Mohit Kumar, Kim, So Young, Armstrong, Andrew J., Somarelli, Jason A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203420/ https://www.ncbi.nlm.nih.gov/pubmed/37228586 http://dx.doi.org/10.3389/fmolb.2023.1104505 |
Ejemplares similares
-
Enzalutamide-Resistant Progression of Castration-Resistant Prostate Cancer Is Driven via the JAK2/STAT1-Dependent Pathway
por: Luo, Yong, et al.
Publicado: (2021) -
Snail promotes resistance to enzalutamide through regulation of androgen receptor activity in prostate cancer
por: Ware, Kathryn E., et al.
Publicado: (2016) -
Proteomimetics of Natural Regulators of JAK–STAT Pathway: Novel Therapeutic Perspectives
por: La Manna, Sara, et al.
Publicado: (2022) -
Molecular determinants for enzalutamide-induced transcription in prostate cancer
por: Yuan, Fuwen, et al.
Publicado: (2019) -
RAC3 Promotes Proliferation, Migration and Invasion via PYCR1/JAK/STAT Signaling in Bladder Cancer
por: Cheng, Chuanyu, et al.
Publicado: (2020)